CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 1,237 enrolled
Drug / intervention
Polyethylene glycol (PEG)drug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02657564
NCT02657564N/ACompleted
CompareCT.gov

The Renal Safety of Bowel Preparation With Polyethylene Glycol for Colonoscopy: A Prospective Cohort Study

Evergreen General Hospital, Taiwan·interventional·Posted Jan 18, 2016·Updated Feb 5, 2019

In Brief

A clinical study evaluating Polyethylene glycol (PEG) for Acute Kidney Injury. Completed, enrolled 1,237 participants across 1 site.

Detailed Summary

This study evaluates the changes of renal function after taking bowel cleansing agent polyethylene glycol for elective colonoscopy.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAcute Kidney Injury
CountriesTaiwan
Collaborators--

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedJan 18, 2016
Enrollment StartJan 1, 2016
Primary CompletionJun 30, 2017
TodayJul 2, 2026
Enrollment to primary: 1.5 yearsPosted 10.5 years ago

Interventions

Polyethylene glycol (PEG)drug

Participants receive blood tests for serum creatinine and electrolytes (Ca, P, Cl, Mg, Na, K) before and after taking polythylene glycol.